134 related articles for article (PubMed ID: 36947280)
1. Brain metastases from hepatopancreatobiliary malignancies.
Bergen ES; Friedrich A; Scherleitner P; Ferreira P; Kiesel B; Widhalm G; Kiesewetter B; Eckert F; Prager GW; Preusser M; Berghoff AS
Clin Exp Metastasis; 2023 Apr; 40(2):177-185. PubMed ID: 36947280
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
Jordan EJ; Lowery MA; Basturk O; Allen PJ; Yu KH; Tabar V; Beal K; Reidy DL; Yamada Y; Janjigian Y; Abou-Alfa GK; O'Reilly EM
Clin Colorectal Cancer; 2018 Jun; 17(2):e315-e321. PubMed ID: 29496399
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome.
Krug S; Teupe F; Michl P; Gress TM; Rinke A
BMC Cancer; 2019 Apr; 19(1):362. PubMed ID: 30991982
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
5. Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases.
Bergen ES; Berghoff AS; Medjedovic M; Rudas M; Fitzal F; Bago-Horvath Z; Dieckmann K; Mader RM; Exner R; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
Clin Cancer Res; 2019 May; 25(9):2737-2744. PubMed ID: 30647078
[TBL] [Abstract][Full Text] [Related]
6. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.
Elshami M; Ahmed FA; Hue JJ; Kakish H; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2023 Feb; 173(2):289-298. PubMed ID: 36402613
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.
Jiang XB; Ke C; Zhang GH; Zhang XH; Sai K; Chen ZP; Mou YG
BMC Cancer; 2012 Feb; 12():49. PubMed ID: 22292912
[TBL] [Abstract][Full Text] [Related]
8. [Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors in 31 cases].
Zhang RL; Zhang H; Zhang L; Xiao L; Sun YN; Yang Y; Bao YX
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):305-9. PubMed ID: 27087379
[TBL] [Abstract][Full Text] [Related]
9. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
11. Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?
Sperduto PW; Fang P; Li J; Breen W; Brown PD; Cagney D; Aizer A; Yu J; Chiang V; Jain S; Gaspar LE; Myrehaug S; Sahgal A; Braunstein S; Sneed P; Cameron B; Attia A; Molitoris J; Wu CC; Wang TJC; Lockney N; Beal K; Parkhurst J; Buatti JM; Shanley R; Lou E; Tandberg DD; Kirkpatrick JP; Shi D; Shih HA; Chuong M; Saito H; Aoyama H; Masucci L; Roberge D; Mehta MP
Transl Res; 2019 Jun; 208():63-72. PubMed ID: 30885538
[TBL] [Abstract][Full Text] [Related]
12. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience.
Falkson SR; Bhambhvani HP; Hayden Gephart M
World Neurosurg; 2020 Aug; 140():e27-e32. PubMed ID: 32289508
[TBL] [Abstract][Full Text] [Related]
14. FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience.
Hrudka J; Prouzová Z; Mydlíková K; Jedličková K; Holešta M; Whitley A; Havlůj L
Pathol Oncol Res; 2021; 27():1609756. PubMed ID: 34257615
[TBL] [Abstract][Full Text] [Related]
15. Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery.
Stenman M; Benmakhlouf H; Wersäll P; Johnstone P; Hatiboglu MA; Mayer-da-Silva J; Harmenberg U; Lindskog M; Sinclair G
Acta Neurochir (Wien); 2021 Feb; 163(2):333-342. PubMed ID: 32902689
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
17. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma.
Lim S; Lee S; Lim JY; Park JS; Seong JS; Chang WS; Han KH; Choi HJ
J Neurooncol; 2014 Oct; 120(1):199-207. PubMed ID: 25062667
[TBL] [Abstract][Full Text] [Related]
19. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]